Studies have demonstrated that chemerin/CMKLR1 signaling plays an essential role in the recruitment of CMKLR1expressing cells to sites of localized inflammation or tissue damage and also correlated with development of NAFLD [7–9]. The gene discussed is CMKLR1; the disease is metabolic dysfunction-associated steatotic liver disease.